These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9001447)

  • 1. The effect of alpha 1-blocking vasodilator on fetal growth and uteroplacental blood flow in streptozotocin-induced diabetic rats.
    Takenaka Y; Toyoda N
    Life Sci; 1995 Feb; 56(13):1127-34. PubMed ID: 9001447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uteroplacental hemodynamic disturbances in establishment of fetal growth retardation in streptozocin-induced diabetic rats.
    Chartrel NC; Clabaut MT; Boismare FA; Schrub JC
    Diabetes; 1990 Jun; 39(6):743-6. PubMed ID: 2140805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect induced by a beta-adrenoceptor blocker on fetal growth in streptozotocin-diabetic rats.
    Clabaut M; Stirnemann B; Bouftila B; Robert I
    Biol Neonate; 1997; 71(3):171-80. PubMed ID: 9096896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and fetal insulin-like growth factor system and embryonic survival during pregnancy in rats: interaction between dietary chromium and diabetes.
    Spicer MT; Stoecker BJ; Chen T; Spicer LJ
    J Nutr; 1998 Dec; 128(12):2341-7. PubMed ID: 9868179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal growth of fetuses from streptozotocin diabetic rat mothers: in vivo and in vitro studies.
    Heinze E; Vetter U
    Diabetologia; 1987 Feb; 30(2):100-3. PubMed ID: 3552823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered nephrogenesis due to maternal diabetes is associated with increased expression of IGF-II/mannose-6-phosphate receptor in the fetal kidney.
    Amri K; Freund N; Duong Van Huyen JP; Merlet-Bénichou C; Lelièvre-Pégorier M
    Diabetes; 2001 May; 50(5):1069-75. PubMed ID: 11334410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats.
    Simán CM; Eriksson UJ
    Diabetes; 1997 Jun; 46(6):1054-61. PubMed ID: 9166679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of maternal hyperglycemia on fetal growing mechanism].
    Kobayashi A; Ueda Y; Morikawa H; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):289-96. PubMed ID: 1828480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of maternal vanadate treatment of fetal development.
    Ganguli S; Reuland DJ; Franklin LA; Deakins DD; Johnston WJ; Pasha A
    Life Sci; 1994; 55(16):1267-76. PubMed ID: 7934628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth assessment of diabetic rat fetuses under the influence of insulin and melatonin: a morphologic study.
    Salem AH; Nosseir NS; El Badawi MG; Shoair MI; Fadel RA
    Anthropol Anz; 2010; 68(2):129-38. PubMed ID: 21452678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of insulin and myo-inositol on embryo growth and development during early organogenesis in streptozocin-induced diabetic rats.
    Akashi M; Akazawa S; Akazawa M; Trocino R; Hashimoto M; Maeda Y; Yamamoto H; Kawasaki E; Takino H; Yokota A
    Diabetes; 1991 Dec; 40(12):1574-9. PubMed ID: 1756898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental dysfunction in Suramin-treated rats: impact of maternal diabetes and effects of antioxidative treatment.
    Nash P; Olovsson M; Eriksson UJ
    J Soc Gynecol Investig; 2005 Apr; 12(3):174-84. PubMed ID: 15784502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased uterine blood flow in the diabetic pregnant rat does not modify the augmented glucose transfer to the fetus.
    Palacín M; Lasunción MA; Martín A; Herrera E
    Biol Neonate; 1985; 48(4):197-203. PubMed ID: 4063414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density and composition in rat pregnancy: effects of streptozotocin-induced diabetes mellitus and insulin replacement.
    Tein MS; Breen SA; Loveday BE; Devlin H; Balment RJ; Boyd RD; Sibley CP; Garland HO
    Exp Physiol; 1998 Mar; 83(2):165-74. PubMed ID: 9568476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trigonelline Inhibits Inflammation and Protects β Cells to Prevent Fetal Growth Restriction during Pregnancy in a Mouse Model of Diabetes.
    Zhou JY; Du XH; Zhang Z; Qian GS
    Pharmacology; 2017; 100(5-6):209-217. PubMed ID: 28723688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal insulin treatment improves pre-implantation embryo development in diabetic rats.
    De Hertogh R; Vanderheyden I; Pampfer S; Robin D; Delcourt J
    Diabetologia; 1992 May; 35(5):406-8. PubMed ID: 1521719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional alterations of type I insulin-like growth factor receptor in placenta of diabetic rats.
    Hauguel-de Mouzon S; Louizeau M; Girard J
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):273-9. PubMed ID: 1445271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional perturbations in infants of diabetic mothers and intrauterine growth retardation.
    Warshaw JB
    Semin Perinatol; 1991 Dec; 15(6):456-61. PubMed ID: 1803522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood levels of insulin-like growth factors I and II in neonates of non-insulin-dependent diabetic rats.
    Levy J; Gavin JR
    Acta Diabetol; 1994 Sep; 31(3):164-8. PubMed ID: 7827357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and renal characteristics, and responses to acute volume expansion of a rat model of diabetic pregnancy.
    Tang D; Yu T; Khraibi AA
    Life Sci; 2004 Apr; 74(23):2909-18. PubMed ID: 15050428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.